-
-
-
-
-
-
-
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
-
-
-
-
-
-
-
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026
-
-
-
-
-
-
-
Roivant Sciences (ROIV) PT Raised to $25 at Guggenheim
-
-
-
-
-
-
-
Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025
-
-
-
-
-
-
-
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update
-
-
-
-
-
-
-
Roivant Sciences Ltd. (ROIV) Tops Q4 EPS by 9c
-
-
-
-
-
-
-
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2023, and Provides Business Update
-
1,233,832 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


